In a research report issued Tuesday, Needham analyst Alan Carr reiterated a Hold rating on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), after the drug maker reported third-quarter results and …
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the third quarter endedSeptember 30, 2016, and provided a corporate update.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced that Dr.
Eisai Inc. and Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced the formation of Beacon Discovery Inc.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the second quarter ended June 30, 2016, and provided a corporate update.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai Inc.
The biotechnology sector is always volatile, and the recent market sell-off only makes it more so. Consequently, Alan Carr of Needham notes that …
In a research report released Friday, Needham’s healthcare analyst Alan Carr reiterated a Hold rating on shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), ahead of the company’s …
Needham’s healthcare analyst Alan Carr weighed in today with an update on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), after the company reported first-quarter financial results and held a …
